AI-generated summary
This review assesses research on photobiomodulation using light-emitting diodes for retinal conditions, including age-related macular degeneration, retinitis pigmentosa, and diabetic retinopathy. The authors describe LEDs as a lower-cost option that can treat large areas. The abstract does not report specific pooled clinical results or a definitive conclusion about effectiveness.
- Who or what was studied
- Patients with various retinal conditions, including age-related macular degeneration, retinopathy of prematurity, retinitis pigmentosa, diabetic retinopathy, Leber's hereditary optic neuropathy, amblyopia, and methanol-induced retinal damage
- Wavelengths
- 500, 1000 nm
- Limits stated in the abstract
- The abstract does not state the number or quality of included studies, and it does not report the strength of the clinical evidence.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on dovepress.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 500 to 1000 nm
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Light-emitting diode, Photobiomodulation, Near-infrared, Age-related macular degeneration, Phototherapy, Neuropathy, Retina. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.